Catabasis Pharmaceuticals, Inc. CATB
8.54 +8.54
Day range unavailable
52-week range unavailable
News
benzinga.com Catabasis Renames As Astria Therapeutics With New Disease Focus Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ: CATB) is looking to hit the reset button with a new name and focus. Catabasis has been dragging for several years, weighed down mainly by the…
benzinga.com Stocks That Hit 52-Week Highs On Wednesday Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs.
pulse2.com Catabasis Pharmaceuticals Shares: 1-For-6 Split Goes Into Effect Catabasis Pharmaceuticals Inc (NASDAQ: CATB) deployed a reverse stock split of its shares of common stock at a ratio of 1-for-6. These are the details.
seekingalpha.com Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
pulse2.com CATB Stock Price Increases Over 40% Pre-Market: Why It Happened The stock price of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) increased by over 40% pre-market. This is why it happened.
businesswire.com Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
benzinga.com 76 Biggest Movers From Yesterday Gainers
businesswire.com Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
benzinga.com 60 Stocks Moving In Thursday's Mid-Day Session Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 284% to $6.15 after the company disclosed positive topline EB613 Phase 2 biomarker data.
247wallst.com AEP, Oracle, Tesla and More Thursday Afternoon Analyst Calls With the trading day halfway over, the broad markets were making yet another strong push.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2021 
benzinga.com 38 Stocks Moving in Thursday's Pre-Market Session Gainers Nova LifeStyle, Inc. (NASDAQ: NVFY) shares rose 195.4% to $7.09 in pre-market trading.
businesswire.com Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences.- benzinga.com 102 Biggest Movers From Yesterday Gainers Leisure Acquisition Corp. (NASDAQ: LACQ) shares jumped 111.2% to close at $23.99 on Monday after the company entered into a merger agreement for business combination with Ensysce Biosciences,…
benzinga.com 88 Biggest Movers From Friday Gainers Siebert Financial Corp. (NASDAQ: SIEB) shares climbed 121.6% to close at $8.22 on Friday on heavy volume.
benzinga.com Mid-Afternoon Market Update: Dow Tumbles 450 Points; Catabasis Pharmaceuticals Shares Spike Higher Toward the end of trading Friday, the Dow traded down 1.47% to 30,153.13 while the NASDAQ fell 1.56% to 13,129.54. The S&P also fell, dropping 1.43% to 3,733.22.
investorplace.com CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today Catabasis Pharma (CATB) stock is soaring higher on Friday after announcing its acquisition of Quellis Biosciences and a PIPE. The post CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today…
businesswire.com Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc. BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that it has acquired Quellis Biosciences Inc. (“Quellis”), a privately-held…
investorplace.com Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Investors to Know Catabasis Pharmaceuticals (CATB) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company. The post Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock…- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 129 companies set new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low was Wells Fargo (NYSE: WFC).
investorplace.com Catabasis Pharmaceuticals News: Why CATB Stock Is Plummeting 69% Today Catabasis Pharmaceuticals (CATB) news for Tuesday includes incredibly poor results from a clinical trial hammering CATB stock hard. The post Catabasis Pharmaceuticals News: Why CATB Stock Is…
benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 127 stocks hit new 52-week highs.
businesswire.com SAB Biotherapeutics annonce le dosage du premier patient de l’essai clinique de phase 1b de SAB-185 pour le traitement du COVID-19 SAB Biotherapeutics announces the first patient dosed in its Phase 1B study evaluating SAB-185, the second study initiated this month for COVID-19.
dentistry.co.uk Dentistry – your ticket around the globe? Part three – Dentistry Online Thinking of moving abroad? Roshan Bains explores what requirements dentists need to practise elsewhere. In part two, he looks at UAE and Singapore.
businesswire.com SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-185 for the Treatment and Prevention of COVID-19 SAB Biotherapeutics (SAB), a clinical stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high
benzinga.com Earnings Scheduled For August 10, 2020 Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ:ACTG) is expected to report quarterly loss at $0.02 per share on revenue of $200.00 thousand.
businesswire.com Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress
benzinga.com The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
patch.com Questions; Confusion Regarding Military Medical System Your kidneys are failing and your doctor has just deployed. Now what?
businesswire.com SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program SAB Biotherapeutics awarded $35.6M from U.S. Department of Defense for COVID-19 therapeutic and scaling Rapid Response Antibody Program.
wholefoodsmagazine.com Study: Benefits of Omega-3 on Alzheimer's Patients Reliant on Dose | WholeFoods Magazine Sioux Falls, SD—Alzheimer’s patients may need higher omega-3 intakes to see benefits than previously thought, according to a study published in The Lancet. The study looked at 33 men and women from…- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com 48 Stocks Moving In Wednesday's Mid-Day Session
- benzinga.com Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018
- benzinga.com Stocks Which Set New 52-Week Lows Friday, August 3rd
benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 2nd - benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 1st
- benzinga.com Stocks Which Set New 52-Week Lows Yesterday:
- benzinga.com 13 Emerging Biotech Companies With Catalysts In 2017